Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...
19h
Market Recap: Tech Strength Drives Nasdaq as All Eyes Turn to Earnings From Palantir, Uber, and AMD
Tech strength drives the Nasdaq. Semis pop. A major consumer deal hits the tape. EV sales cool. Earnings on deck include ...
Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.
The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD ...
Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...
Free Malaysia Today on MSN
Pfizer, Tris Pharma settle for $41.5 million in Texas ADHD drug case
Texas's top prosecutor on Wednesday announced the state had reached a $41.5 million settlement with US drugmakers Pfizer and ...
Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...
Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM ESTCompany ParticipantsDavid Denton - Executive VP ...
Investing.com -- Pfizer Inc plans to expand its obesity portfolio globally with a focus on oral medications following its Metsera acquisition, Chief Financial Officer Dave Denton said at the Jefferies ...
In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback